. Author manuscript; available in PMC: 2016 Dec 28.

Published in final edited form as: Cancer. 2015 Oct 6;121(24):4382–4388. doi: 10.1002/cncr.29664

Table 3.

Germline Mutation Prevalence in Pancreatic Cancer Patient Cohorts.

Patient population	N	Number of patients tested	Pathogenic mutation identified	BRCA1 mutation	BRCA2 mutation	Other Gene
Ashkenazi Jewish	98	96	15 (15.6%)	2	11	2
Non-Ashkenazi Jewish	77	63	9 (14.3%)	2	2	5
Early-onset (age ≤50)	26	21	6 (28.6%)	2	0	4
Late-onset (age ≥70)	51	46	3 (6.5%)	2	1	0
Familial Pancreatic	40	34	2 (5.9%)	1	1	0